Aigh Capital Management LLC Paratek Pharmaceuticals, Inc. Transaction History

Aigh Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.37 - $2.54 $2.03 Million - $3.76 Million	-1,482,079 Reduced 35.65%	2,674,812 $6.79 Million
Q4 2022 Feb 14, 2023	BUY	$1.67 - $2.51 $450,430 - $676,994	269,719 Added 6.94%	4,156,891 $7.77 Million
Q3 2022 Nov 10, 2022	BUY	$1.96 - $2.93 $980,000 - $1.47 Million	500,000 Added 14.76%	3,887,172 $9.99 Million
Q2 2022 Aug 12, 2022	BUY	$1.73 - $3.09 $428,102 - $764,645	247,458 Added 7.88%	3,387,172 $6.54 Million
Q1 2022 May 12, 2022	BUY	$2.94 - $4.77 $2.35 Million - $3.82 Million	800,607 Added 34.23%	3,139,714 $9.33 Million
Q4 2021 Feb 10, 2022	BUY	$4.07 - $5.3 $2.97 Million - $3.87 Million	729,709 Added 45.34%	2,339,107 $10.5 Million
Q3 2021 Nov 12, 2021	BUY	$4.7 - $7.24 $3.23 Million - $4.97 Million	686,619 Added 74.41%	1,609,398 $7.82 Million
Q2 2021 Aug 12, 2021	BUY	$6.81 - $10.93 $1.18 Million - $1.89 Million	173,171 Added 23.1%	922,779 $6.29 Million
Q4 2020 Feb 16, 2021	BUY	$4.58 - $7.14 $3.43 Million - $5.35 Million	749,608 New	749,608 $4.69 Million

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Aigh Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aigh Capital Management LLC with notifications on news.